Immatics is an English word starting with the letter I. With 3 example sentences you'll see exactly how it works in context.
Immatics in a sentence
Context around Immatics
- Average sentence length in these examples: 15.7 words
- Position in the sentence: 1 start, 2 middle, 0 end
- Sentence types: 3 statements, 0 questions, 0 exclamations
Corpus analysis for Immatics
- In this selection, "immatics" usually appears in the middle of the sentence. The average example has 15.7 words, and this corpus slice is mostly made up of statements.
- Around the word, biotechnologies and current stand out and add context to how "immatics" is used.
- Recognizable usage signals include estimate for immatics current full and immatics has several. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "immatics" sits close to words such as aaai, aani and aarne, which helps place it inside the broader word index.
Example types with immatics
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
The consensus estimate for Immatics’ current full-year earnings is ($1.41) per share. (14 words)
Immatics has several TCR therapy candidates in clinical development, according to its pipeline page. (14 words)
Jefferies Financial Group Inc. bought a new position in immatics biotechnologies during the fourth quarter worth about $80,000. (19 words)
Jefferies Financial Group Inc. bought a new position in immatics biotechnologies during the fourth quarter worth about $80,000. (19 words)
The consensus estimate for Immatics’ current full-year earnings is ($1.41) per share. (14 words)
Immatics has several TCR therapy candidates in clinical development, according to its pipeline page. (14 words)
Example sentences (3)
Jefferies Financial Group Inc. bought a new position in immatics biotechnologies during the fourth quarter worth about $80,000.
The consensus estimate for Immatics’ current full-year earnings is ($1.41) per share.
Immatics has several TCR therapy candidates in clinical development, according to its pipeline page.